INTERNATIONAL PATENT: ONCOMATRYX BIOPHARMA, S.L. FILES APPLICATION FOR "FAP TARGETED ANTIBODY-DRUG CONJUGATES"

GENEVA, Sept. 21 -- ONCOMATRYX BIOPHARMA, S.L. (801-B PARQUE TECNOLOGICO DE BIZKAIADerio Bizkaia) filed a patent application (PCT/EP2025/057062) for "FAP TARGETED ANTIBODY-DRUG CONJUGATES" on Mar 14, 2025. With publication no. WO/2025/191153, the details related to the patent application was published on Sep 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): EGAÑA GANUZA, Isabel (c/o Oncomatryx Biopharma, S.L.801-B PARQUE TECNOLOGICO DE BIZKAIADerio Bizkaia), FABRE, Myriam (c/o Oncomatryx Biopharma, S.L.801-B PARQUE TECNOLOGICO DE BIZKAIADerio Bizkaia), SIMON BUELA, Laureano (c/o Oncom...